VVOS

NASDAQStock

Vivos Therapeutics, Inc.

$1.26-0.04 (-3.08%)

52-Week Range

$1.30

$6.95

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

7.02

Volume

201.0K

Avg Volume

103.3K

Performance

-16.13%

-35.64%

-61.54%

YTD

-48.62%

-60.61%

-86.42%

-99.30%

Price Chart

ETF Exposure

VVOS is held by 7 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	10	$22	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	373	$819	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	1	$3	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	212,700	$345K	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	1,118	$2K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	96	$211	$1.29B	0.17%
VXF	Vanguard Extended Market ETF	0.00%	60,629	$98K	$84.10B	0.05%

About VVOS ETF Exposure

Vivos Therapeutics, Inc. (VVOS) is held by 7 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $1.26. Investors can gain exposure to VVOS through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold VVOS, sorted by portfolio weight.